rs41290704

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_004393.6(DAG1):​c.599C>G​(p.Thr200Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00204 in 1,614,194 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 7 hom. )

Consequence

DAG1
NM_004393.6 missense

Scores

1
9
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 4.04

Publications

8 publications found
Variant links:
Genes affected
DAG1 (HGNC:2666): (dystroglycan 1) This gene encodes dystroglycan, a central component of dystrophin-glycoprotein complex that links the extracellular matrix and the cytoskeleton in the skeletal muscle. The encoded preproprotein undergoes O- and N-glycosylation, and proteolytic processing to generate alpha and beta subunits. Certain mutations in this gene are known to cause distinct forms of muscular dystrophy. Alternative splicing results in multiple transcript variants, all encoding the same protein. [provided by RefSeq, Nov 2015]
DAG1 Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2P
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated asymptomatic elevation of creatine phosphokinase
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01572135).
BP6
Variant 3-49531110-C-G is Benign according to our data. Variant chr3-49531110-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 196388.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 7 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004393.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DAG1
NM_004393.6
MANE Select
c.599C>Gp.Thr200Ser
missense
Exon 3 of 3NP_004384.5Q14118
DAG1
NM_001165928.4
c.599C>Gp.Thr200Ser
missense
Exon 6 of 6NP_001159400.3Q14118
DAG1
NM_001177634.3
c.599C>Gp.Thr200Ser
missense
Exon 6 of 6NP_001171105.2Q14118

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DAG1
ENST00000308775.7
TSL:1 MANE Select
c.599C>Gp.Thr200Ser
missense
Exon 3 of 3ENSP00000312435.2Q14118
DAG1
ENST00000418588.6
TSL:3
c.599C>Gp.Thr200Ser
missense
Exon 4 of 4ENSP00000405859.2Q14118
DAG1
ENST00000421560.6
TSL:4
c.599C>Gp.Thr200Ser
missense
Exon 3 of 3ENSP00000412067.2Q14118

Frequencies

GnomAD3 genomes
AF:
0.00161
AC:
245
AN:
152182
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00291
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00202
AC:
507
AN:
251490
AF XY:
0.00199
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000549
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00203
Gnomad NFE exome
AF:
0.00376
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.00209
AC:
3052
AN:
1461894
Hom.:
7
Cov.:
32
AF XY:
0.00200
AC XY:
1458
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.000568
AC:
19
AN:
33480
American (AMR)
AF:
0.000514
AC:
23
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000497
AC:
13
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00206
AC:
110
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00250
AC:
2785
AN:
1112012
Other (OTH)
AF:
0.00169
AC:
102
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
218
436
655
873
1091
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00161
AC:
245
AN:
152300
Hom.:
1
Cov.:
32
AF XY:
0.00142
AC XY:
106
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.000505
AC:
21
AN:
41556
American (AMR)
AF:
0.000392
AC:
6
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00104
AC:
11
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00291
AC:
198
AN:
68028
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
15
30
45
60
75
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00228
Hom.:
0
Bravo
AF:
0.00153
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00256
AC:
22
ExAC
AF:
0.00225
AC:
273
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00240
EpiControl
AF:
0.00290

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
3
not provided (3)
-
-
1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9;C4511963:Autosomal recessive limb-girdle muscular dystrophy type 2P (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.040
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.40
T
Eigen
Uncertain
0.50
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.066
D
MetaRNN
Benign
0.016
T
MetaSVM
Benign
-0.32
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
4.0
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-0.85
N
REVEL
Uncertain
0.37
Sift
Benign
0.34
T
Sift4G
Uncertain
0.021
D
Polyphen
0.91
P
Vest4
0.42
MutPred
0.56
Loss of glycosylation at P204 (P = 0.0497)
MVP
0.71
MPC
0.73
ClinPred
0.020
T
GERP RS
5.9
Varity_R
0.16
gMVP
0.35
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41290704; hg19: chr3-49568543; API